Aurobindo Pharma rises on getting final nod for Dapagliflozin, Metformin Hydrochloride Extended-Release Tablets
Mumbai, April 8 (Udaipur Kiran): Aurobindo Pharma is currently trading at Rs. 1341.50, up by 11.90 points or 0.90% from its previous closing of Rs. 1329.60 on the BSE. The scrip opened at Rs. 1369.95 and has touched a high and low of Rs. 1369.95 and Rs. 1333.0 respectively. So far 16794 shares were traded … Read more
